Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

The role of diffusion weighted MR imaging for differentiation between Graves' disease and Hashimoto thyroiditis.

Ozturk T, Bozgeyik Z, Ozturk F, Burakgazi G, Akyol M, Coskun S, Ozkan Y, Ogur E.

Eur Rev Med Pharmacol Sci. 2015 Aug;19(15):2798-803.

PMID:
26241532
2.

Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases.

Mukasa K, Noh JY, Kunii Y, Matsumoto M, Sato S, Yasuda S, Suzuki M, Ito K, Ito K.

Thyroid. 2011 Jan;21(1):37-41. doi: 10.1089/thy.2010.0050. Epub 2010 Oct 9.

PMID:
20932180
3.

Value of shear wave elastography by virtual touch tissue imaging quantification in patients with diffuse thyroid gland pathology

Kural Rahatlı F, Turnaoğlu H, Kırnap NG, Turhan İyidir Ö, Haberal KM, Soudman A, Uslu N.

Turk J Med Sci. 2018 Oct 31;48(5):993-998. doi: 10.3906/sag-1803-235.

PMID:
30384566
4.

Hashimoto's thyroiditis following Graves' disease.

Umar H, Muallima N, Adam JM, Sanusi H.

Acta Med Indones. 2010 Jan;42(1):31-5.

5.

Role of Diffusion-Weighted Magnetic Resonance (MR) Imaging in Differentiation Between Graves' Disease and Painless Thyroiditis.

Abdel Razek AAK, Abd Allah SS, El-Said AAE.

Pol J Radiol. 2017 Sep 15;82:536-541. doi: 10.12659/PJR.902416. eCollection 2017.

6.

Diffusion-weighed MR of the thyroid gland in Graves' disease: assessment of disease activity and prediction of outcome.

Abdel Razek AA, Sadek AG, Gaballa G.

Acad Radiol. 2010 Jun;17(6):779-83. doi: 10.1016/j.acra.2010.01.014. Epub 2010 Mar 28.

PMID:
20350826
7.

Graves' disease associated with alopecia areata developing after Hashimoto's thyroiditis.

Aşık M, Binnetoğlu E, Şen H, Tekeli Z, Uysal F, Ukinç K.

J Nippon Med Sch. 2013;80(6):467-9.

8.

Four cases of Graves' disease which developed after painful Hashimoto's thyroiditis.

Ohye H, Nishihara E, Sasaki I, Kubota S, Fukata S, Amino N, Kuma K, Miyauchi A.

Intern Med. 2006;45(6):385-9. Epub 2006 Apr 17.

9.

Graves' disease following hypothyroidism due to Hashimoto's thyroiditis in a black South African lady: a case report.

Ekpebegh C, Elmezughi K, Mtingi L.

Pan Afr Med J. 2019 Apr 17;32:186. doi: 10.11604/pamj.2019.32.186.18713. eCollection 2019.

10.

Thyroid Ultrasonography in Differentiation between Graves' Disease and Hashimoto's Thyroiditis.

Pishdad P, Pishdad GR, Tavanaa S, Pishdad R, Jalli R.

J Biomed Phys Eng. 2017 Mar 1;7(1):21-26. eCollection 2017 Mar.

11.

MR imaging of the thyroid: correlation between apparent diffusion coefficient and thyroid gland scintigraphy.

Tezuka M, Murata Y, Ishida R, Ohashi I, Hirata Y, Shibuya H.

J Magn Reson Imaging. 2003 Feb;17(2):163-9.

PMID:
12541222
12.

Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease.

Ota H, Amino N, Morita S, Kobayashi K, Kubota S, Fukata S, Kamiyama N, Miyauchi A.

Clin Endocrinol (Oxf). 2007 Jul;67(1):41-5. Epub 2007 Apr 15.

PMID:
17437515
13.

Hashimoto's thyroiditis presenting as Graves-Basedow disease.

Mollar Puchades MA, Merino Torres JF, Pérez Lázaro MA, Segovia Portolés R, Abellán Galiana P, Piñón Sellés F.

Thyroid. 2007 Nov;17(11):1151-2. No abstract available.

PMID:
17822375
14.

Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis.

Vitti P, Rago T, Mazzeo S, Brogioni S, Lampis M, De Liperi A, Bartolozzi C, Pinchera A, Martino E.

J Endocrinol Invest. 1995 Dec;18(11):857-61.

PMID:
8778158
15.

Re-establishment of normal radioactive iodine uptake reference range in the era of universal salt iodization in the Indian population.

Ballal S, Soundararajan R, Bal C.

Indian J Med Res. 2017 Mar;145(3):358-364. doi: 10.4103/ijmr.IJMR_1158_14.

16.

[Surgical procedures in patients with thyroid autoimmune disease].

Diklić A, Zivaljević V, Paunović I, Kalezić N, Tatić S.

Srp Arh Celok Lek. 2005 Oct;133 Suppl 1:77-83. Serbian.

17.

[Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].

Yuan S, Yu N, Gao Y, Huang W, He Y, Dong B, Lu G, Li M, Cai X, Peng D, Wang Y, Li T, Huang Y, Gao Y, Guo X, Shi B.

Zhonghua Yi Xue Za Zhi. 2014 Jan 14;94(2):110-4. Chinese.

PMID:
24721350
18.

Possible association of CEA expression with oxyphilic change but not with C-cell hyperplasia in Hashimoto's thyroiditis.

Gakiopoulou H, Litsiou E, Valaris K, Balafoutas D, Patsouris E, Tseleni-Balafouta S.

Endocr J. 2010;57(8):693-9. Epub 2010 Jul 3.

19.

Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease.

Boelaert K, Newby PR, Simmonds MJ, Holder RL, Carr-Smith JD, Heward JM, Manji N, Allahabadia A, Armitage M, Chatterjee KV, Lazarus JH, Pearce SH, Vaidya B, Gough SC, Franklyn JA.

Am J Med. 2010 Feb;123(2):183.e1-9. doi: 10.1016/j.amjmed.2009.06.030.

PMID:
20103030
20.

Hot and cold: coexistent Graves' disease and Hashimoto's thyroiditis in a patient with Schmidt's syndrome.

Dasari S, Naha K, Hande M, Vivek G.

BMJ Case Rep. 2014 May 21;2014. pii: bcr2013010432. doi: 10.1136/bcr-2013-010432.

Supplemental Content

Support Center